Enliven Therapeutics

ELVN

Enliven Therapeutics has been a target of short sellers for a while. The current short interest of 11.74% is roughly at the average of the last 12 months (9.97%).

Short Interest Trend

Share Price

Total NSP

11.74%

+0.47%

vs. last month

Also interesting? All insider buys at Enliven Therapeutics

Found an error? Questions? Ideas?